Celera Corporation (NASDAQ:CRA) announced today that it will webcast its
presentation at the Eighth Annual JMP Securities Research Conference on
Monday, May 18, 2009. The presentation is scheduled to begin at 11:00
a.m. PT (2:00 p.m. ET), when Kathy Ordoñez, Chief Executive Officer of
Celera, will provide an overview of the business.
Interested parties may access the live webcast and replay by visiting
the Media and Investors section of the Celera website at www.celera.com.
It is suggested that participants access the webcast 15 minutes before
the start of the live broadcast. The webcast replay will be archived on
the Presentations page of the Media and Investors section of the website.
About Celera
Celera is a healthcare business delivering personalized disease
management through a combination of products and services incorporating
proprietary discoveries. Berkeley HeartLab, a subsidiary of Celera,
offers services to predict cardiovascular disease risk and improve
patient management. Celera also commercializes a wide range of molecular
diagnostic products through Abbott and has licensed other relevant
diagnostic technologies developed to provide personalized disease
management in cancer and liver diseases. Information about Celera
Corporation, including reports and other information filed by the
company with the Securities and Exchange Commission, is available at http://www.celera.com.
Copyright© 2009. Celera Corporation. All Rights Reserved. Celera is a
registered trademark of Celera Corporation or its subsidiaries in the
U.S. and/or certain other countries.
Celera Corporation
David Speechly, Ph.D.
510-749-1853
David.Speechly@celera.com
